|
PSMD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.442000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.224990E-01 |
| Normal-vs-Stage2 |
7.764200E-01 |
| Normal-vs-Stage3 |
3.390800E-01 |
| Normal-vs-Stage4 |
7.972400E-01 |
| Stage1-vs-Stage2 |
3.364600E-01 |
| Stage1-vs-Stage3 |
9.787900E-02 |
| Stage1-vs-Stage4 |
9.497200E-01 |
| Stage2-vs-Stage3 |
6.864400E-01 |
| Stage2-vs-Stage4 |
6.757400E-01 |
| Stage3-vs-Stage4 |
5.671400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.350800E-01 |
| Normal-vs-AfricanAmerican |
7.511200E-01 |
| Normal-vs-Asian |
8.814000E-01 |
| Caucasian-vs-AfricanAmerican |
4.988400E-01 |
| Caucasian-vs-Asian |
9.758800E-01 |
| AfricanAmerican-vs-Asian |
7.774600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.682200E-02 |
| Normal-vs-Female |
9.769000E-04 |
| Male-vs-Female |
1.92552999999096E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.876400E-01 |
| Normal-vs-Extreme_Weight |
1.986060E-02 |
| Normal-vs-Obese |
8.753800E-01 |
| Normal-vs-Extreme_Obese |
7.515200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.255400E-01 |
| Normal_Weight-vs-Obese |
8.158200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.847200E-01 |
| Extreme_Weight-vs-Obese |
5.219500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.688600E-01 |
| Obese-vs-Extreme_Obese |
7.229200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.038600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.960200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.529800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.961620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.659800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.658000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.706000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.944600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.317200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.998800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.430000E-01 |
| Normal-VS-Type2 PRCC |
7.325400E-01 |
| Normal-VS-KIRP CIMP |
3.544200E-01 |
| Normal-VS-Unclassified PRCC |
2.538400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.309400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.739200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.906000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.649600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.076800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.961200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.322100E-02 |
| Normal-vs-N1 |
2.891400E-01 |
| Normal-vs-N2 |
4.777800E-01 |
| N0-vs-N1 |
3.057600E-02 |
| N0-vs-N2 |
3.763600E-01 |
| N1-vs-N2 |
3.854600E-01 |
|
|
